Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer Research

• Publication date

  2018-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-17-1733PMID 29321163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target

  2017cited by this paper
• Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62

  2017cited by this paper
• Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo

  2016cited by this paper
• Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.

  2016cited by this paper
• Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells

  2016cited by this paper
• Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis

  2016cited by this paper
• The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.

  2016cited by this paper
• Ponatinib in the therapy of chronic myeloid leukemia

  2016cited by this paper
• RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia

  2016cited by this paper
• Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib

  2016cited by this paper
• Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells

  2016cited by this paper
• Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo

  2016cited by this paper
• Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.

  2016cited by this paper
• Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.

  2015cited by this paper
• NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma

  2015cited by this paper
• MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

  2015cited by this paper
• Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm.

  2015cited by this paper
• p53 causes butein-mediated apoptosis of chronic myeloid leukemia cells

  2015cited by this paper
• Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors

  2015cited by this paper
• Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

  2015cited by this paper
• Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study

  2015cited by this paper
• CSN6 drives carcinogenesis by positively regulating Myc stability

  2014cited by this paper
• Protein neddylation: beyond cullin–RING ligases

  2014cited by this paper
• BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.

  2014cited by this paper
• PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

  2014cited by this paper
• Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression.

  2013cited by this paper
• Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer

  2013cited by this paper
• Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.

  2012cited by this paper
• The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.

  2012cited by this paper
• The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells

  2012cited by this paper
• Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

  2012cited by this paper
• Targeting neddylation in cancer therapy.

  2012cited by this paper
• hSSB1 regulates both the stability and the transcriptional activity of p53

  2012cited by this paper
• Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.

  2011cited by this paper
• Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.

  2011cited by this paper
• Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.

  2010cited by this paper
• NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

  2010cited by this paper
• Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation.

  2010cited by this paper
• Role of BCR-ABL-Y177 mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors

  2009cited by this paper
• An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

  2009cited by this paper
• The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-α-expressing cells through caspase-3-mediated cleavage of Mcl-1

  2007cited by this paper
• Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

  2006cited by this paper
• The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity

  1999cited by this paper
• Chronic myeloid leukemia.

  1999cited by this paper
• Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.

  1994cited by this paper
• p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression

  1988cited by this paper

• Pevonedistat targeting NEDDylation activating enzyme for human diseases: Underlying mechanisms, clinical studies, and future directions.

  2026cites this paper
• Decoding neddylation in malignancies: molecular mechanisms, biological functions, therapeutic resistance, and clinical potential

  2026cites this paper
• SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression

  2025cites this paper
• Neddylation status determines the therapeutic sensitivity of tyrosine kinase inhibitors in chronic myeloid leukemia

  2025cites this paper
• RAPSYN-mediated neddylation of BCR-ABL alternatively determines the fate of Philadelphia chromosome-positive leukemia

  2024cites this paper
• Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN

  2024cites this paper
• Protein neddylation and its role in health and diseases

  2024cites this paper
• Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia

  2023cites this paper
• Targeting cullin neddylation for cancer and fibrotic diseases

  2023cites this paper
• System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.

  2023cites this paper
• I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition

  2023cites this paper
• Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL

  2022cites this paper
• Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer

  2022cites this paper
• Artemisia vulgaris inhibits BCR/ABL and promotes apoptosis in chronic myeloid leukemia cells.

  2022cites this paper
• Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability

  2021cites this paper
• Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6

  2021influential citation
• Reporters of Cancer Stem Cells as a Tool for Drug Discovery

  2021cites this paper
• Role of neddylation in neurological development and diseases

  2021cites this paper
• E1 Enzymes as Therapeutic Targets in Cancer

  2021cites this paper
• Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis

  2021cites this paper
• DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway

  2021cites this paper
• Discovery of Berberine that Targetedly Induces Autophagic Degradation of both BCR-ABL and BCR-ABL T315I through Recruiting LRSAM1 for Overcoming Imatinib Resistance

  2020cites this paper
• Targeting neddylation inhibits intravascular survival and extravasation of cancer cells to prevent lung-cancer metastasis

  2019cites this paper
• The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors

  2019influential citation
• PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent inducer of apoptosis in chronic myelogenous leukemia cells.

  2019cites this paper
• Identification of p53 Activators in a Human Microarray Compendium.

  2019cites this paper
• Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer

  2019cites this paper
• MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5

  2018cites this paper
• Phenotype and target-based chemical biology investigations in cancers

  2018influential citation
• Special Topic: Chemistry and Molecular Medicine Phenotypes and targets-based chemical biology investigations in cancers

  2018cites this paper